65 studies found for:    Medivation
Show Display Options
Rank Status Study
21 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon
22 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
23 Completed An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Condition: Huntington Disease
Intervention: Drug: Dimebon (latrepirdine)
24 Completed Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
Condition: Hepatic Failure
Intervention: Drug: Dimebon
25 Completed A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
Conditions: Alzheimer's Disease;   Huntington's Disease
Intervention: Drug: Dimebon
26 Active, not recruiting A Study to Test if MDV3100 is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Condition: Prostate Cancer
Intervention: Drug: MDV3100
27 Completed A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects
Conditions: Healthy Subjects;   Castration Resistant Prostate Cancer (CRPC);   Relative Bioavailability;   MDV3100
Intervention: Drug: MDV3100
28 Terminated
Has Results
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon tablet for oral administration
29 Completed Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group
Conditions: Pharmacokinetics of MDV3100;   Healthy Subjects;   Kidney Diseases
Intervention: Drug: MDV3100
30 Completed A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
Conditions: Alzheimer's Disease;   Huntington's Disease
Intervention: Drug: Dimebon
31 Approved for marketing Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: MDV3100
32 Recruiting A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
33 Recruiting Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Conditions: Advanced Epithelial Ovarian;   Recurrent Epithelial Ovarian;   Fallopian Tube;   Primary Peritoneal Carcinoma.
Intervention: Drug: Enzalutamide
34 Recruiting Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
Condition: Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: Enzalutamide;   Drug: LHRHa
35 Recruiting A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Condition: Metastatic Castration- Resistant Prostate Cancer (mCRCP)
Intervention: Drug: Enzalutamide
36 Completed Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Conditions: Prostate Cancer;   Pharmacokinetics of Enzalutamide
Interventions: Drug: Enzalutamide tablet;   Drug: Enzalutamide capsule
37 Recruiting Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Goserelin acetate;   Drug: Leuprolide acetate;   Radiation: Radiation therapy
38 Not yet recruiting A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Conditions: Prostate Cancer;   Castration-Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
39 Recruiting Enzalutamide With or Without Abiraterone Acetate and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: abiraterone;   Drug: prednisone
40 Recruiting Phase II Trial of Enzalutamide for Castrate-resistant Prostate Cancer With Correlative Assessment of Androgen Receptor Signaling
Condition: Prostate Cancer
Intervention: Drug: Enzalutamide

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years